Clinical trial
Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children…
NCT00152126 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00152126 |
|---|---|
| Title | Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas |
| Official title | Busulfan and Melphalan With Autologous Hematopoietic Stem Cell Support With Positively-Selected CD133+ Hematopoietic Cells for Children With High Risk Solid Tumors and Lymphomas |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Collaborators | University of Miami |
| Status | Completed |
| Study type | Interventional |
| Conditions | Neuroblastoma, Central Nervous System Tumors, Lymphomas, Wilms Tumor |
| Intervention type | Drug, Procedure |
| Interventions | Stem Cell Transplantation, Busulfan, Melphalan |
| Enrollment | 26 |
| Start date | Aug 1, 2003 |
| Primary completion | Aug 1, 2005 |
| Completion | Feb 1, 2009 |
| First posted | Sep 9, 2005 |
| Last update posted | Feb 13, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: